Skip to search formSkip to main contentSkip to account menu

olodaterol

Known as: 6-hydroxy-8-(1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)-2H-1,4-benzoxazin-3(4H)-one 
National Institutes of Health

Related topics

Related topics

8 relations
28 ACTUAT olodaterol 0.0025 MG/ACTUAT Metered Dose Inhaler [Striverdi]60 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Metered Dose InhalerAdrenergic beta2-Agonists [MoA]olodaterol / tiotropium

Broader (3)

Adrenergic beta-1 Receptor AgonistsBenzoxazinesBronchodilator Agents

Narrower (1)

Olodaterol hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients
Background Reduced physical activity is associated with increased morbidity and mortality in patients with COPD. Studies suggest… 
2018
2018
Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity
Purpose This study evaluated the efficacy of tiotropium/olodaterol vs tiotropium on lung function, exercise capacity, and… 
2017
2017
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi
ABSTRACT Equine airways represent a suitable ex vivo model to study the functional impact of pharmacological treatments on human… 
Review
2015
Review
2015
Olodaterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease
Olodaterol (Striverdi® Respimat®) is an inhaled long-acting β2-adrenoceptor agonist (LABA) indicated as a once-daily maintenance… 
2015
2015
Olodaterol Attenuates Citric Acid-Induced Cough in Naïve and Ovalbumin-Sensitized and Challenged Guinea Pigs
Excessive coughing is a common feature of airway diseases. Different G-protein coupled receptors, including β2-adrenergic… 
Review
2014
Review
2014
Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol
Purpose In the absence of head-to-head clinical trials comparing the once-daily, long-acting beta2-agonists olodaterol and… 
2014
2014
Effects of 12 weeks of once-daily tiotropium and olodaterol fixed-dose combination on exercise endurance in patients with COPD
Background : Both tiotropium (T) and olodaterol (O) monotherapies improve exercise endurance in patients with chronic obstructive… 
2014
2014
P258 The 24-hour Lung Function Profile Of Once-daily Tiotropium And Olodaterol Fixed-dose Combination Compared With Placebo And Monotherapies In Chronic Obstructive Pulmonary Disease
Introduction Tiotropium (T), a once-daily long-acting muscarinic antagonist, is a well-established first-line maintenance… 
2013
2013
Lung function efficacy of olodaterol QD delivered via Respimat® in COPD patients: Results from two 48-week studies
Background: The novel inhaled LABA olodaterol (O) has 24-h bronchodilator activity. Objective: To assess the efficacy of O QD in… 
2012
2012
β₂-adrenoceptors and muscarinic receptors mediate opposing effects on endothelin-1 expression in human lung fibroblasts.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)